National Cancer Institute Home at the National Institutes of Health | www.cancer.gov
Please wait while this form is being loaded....

Methods

This section provides a list of selected papers that lay out methods for DCIS reseach as well as brief commentaries. If you would like to add other relevant papers to this list, please contact us.

2009

Lester SC, Connolly JL, Amin MB. College of American Pathologists protocol for the reporting of ductal carcinoma in situ. Arch Pathol Lab Med 2009 Jan;133(1):13-4. [Look up in PubMed]

2008

Pepe MS, Feng Z, Janes H, Bossuyt PM, Potter JD. Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design. J Natl Cancer Inst 2008 Oct 15;100(20):1432-8. [View Abstract]

Ransohoff DF. How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design. J Clin Epidemiol 2007 Dec;60(12):1205-19. [View Abstract]

2007

American College Of Radiology. Practice guideline for the management of ductal carcinoma in-situ of the breast (DCIS). J Am Coll Surg 2007 Jul;205(1):145-161. [View Abstract]

2005

McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics. Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 2005 Aug 17;97(16):1180-4. [View Abstract]

Simon R. Development and validation of therapeutically relevant multi-gene biomarker classifiers. J Natl Cancer Inst. 2005 Jun 15;97(12):866-7. [View Abstract]

2004

Ransohoff DF. Rules of evidence for cancer molecular-marker discovery and validation. Nat Rev Cancer. 2004 Apr;4(4):309-14. [View Abstract]

Last Modified: 18 Oct 2013